Author Kari, Vijayalakshmi
-
2011 | Journal Article
The H2B ubiquitin ligase RNF40 cooperates with SUPT16H to induce dynamic changes in chromatin structure during DNA double-strand break repair
Kari, V.; Shchebet, A.; Neumann, H. & Johnsen, S. A. (2011)
Cell Cycle, 10(20) pp. 3495-3504. DOI: https://doi.org/10.4161/cc.10.20.17769
Details DOI PMID PMC WoS
-
2013 | Journal Article |
A Subset of Histone H2B Genes Produces Polyadenylated mRNAs under a Variety of Cellular Conditions
Kari, V.; Karpiuk, O.; Tieg, B.; Kriegs, M.; Dikomey, E.; Krebber, H. & Begus-Nahrmann, Y. et al. (2013)
PLoS ONE, 8(5) art. UNSP e63745. DOI: https://doi.org/10.1371/journal.pone.0063745
Details DOI PMID PMC WoS
-
2015 | Journal Article
Stem-Cell-like Properties and Epithelial Plasticity Arise as Stable Traits after Transient Twist1 Activation
Schmidt, J. M.; Panzilius, E.; Bartsch, H. S.; Irmler, M.; Beckers, J.; Kari, V. & Linnemann, J. R. et al. (2015)
Cell Reports, 10(2) pp. 131-139. DOI: https://doi.org/10.1016/j.celrep.2014.12.032
Details DOI PMID PMC WoS
-
2016 | Conference Abstract
Kruppel-like Transcription Factor-10 (KLF10) suppresses the TGF beta-induced epithelial-to-mesenchymal transition
Mishra, V. K.; Kari, V.; Subramaniam, M.; Baumgart, S. J.; Nagarajan, S.; Wegwitz, F. & Spelsberg, T. C. et al. (2016)
Cancer Research, 76 American-Association-for-Cancer-Research (AACR) Special Conference on Chromatin and Epigenetics in Cancer, Atlanta, GA.
Philadelphia: Amer Assoc Cancer Research. DOI: https://doi.org/10.1158/1538-7445.CHROMEPI15-A03
Details DOI WoS
-
2016 | Journal Article
Loss of CHD1 causes DNA repair defects and enhances prostate cancer therapeutic responsiveness
Kari, V.; Mansour, W. Y.; Raul, S. K.; Baumgart, S. J. ; Mund, A.; Grade, M. & Sirma, H. et al. (2016)
EMBO Reports, 17(11) pp. 1609-1623. DOI: https://doi.org/10.15252/embr.201642352
Details DOI PMID PMC WoS
-
2017 | Journal Article |
Histone deacetylase class-I inhibition promotes epithelial gene expression in pancreatic cancer cells in a BRD4-and MYC-dependent manner
Mishra, V. K.; Wegwitz, F.; Kosinsky, R. L.; Sen, M. ; Baumgartner, R.; Wulff, T. & Siveke, J. T. et al. (2017)
Nucleic Acids Research, 45(11) pp. 6334-6349. DOI: https://doi.org/10.1093/nar/gkx212
Details DOI WoS
-
2017 | Journal Article |
BRD4 promotes p63 and GRHL3 expression downstream of FOXO in mammary epithelial cells
Nagarajan, S.; Bedi, U.; Budida, A. ; Hamdan, F. H. ; Mishra, V. K.; Najafova, Z. & Xie, W. et al. (2017)
Nucleic Acids Research, 45(6) pp. 3130-3145. DOI: https://doi.org/10.1093/nar/gkw1276
Details DOI PMID PMC WoS
-
2017 | Journal Article |
RNF40 regulates gene expression in an epigenetic context-dependent manner
Xie, W.; Nagarajan, S.; Baumgart, S. J.; Kosinsky, R. L.; Najafova, Z.; Kari, V. & Hennion, M. et al. (2017)
Genome Biology, 18 art. 32. DOI: https://doi.org/10.1186/s13059-017-1159-5
Details DOI PMID PMC WoS
-
2018 | Journal Article
Abstract 1917: CHD1 depletion leads to androgen-independent growth of prostate cancer cells lines and regulates the TGFβ system in an EZH2-dependent manner
Böcker, S. J.; Baumgart, S. J.; Roth, A.; Kari, V.; Johnsen, S. A. & Hahn, O. (2018)
Cancer Research, 78(13_Supplement) pp. 1917-1917. DOI: https://doi.org/10.1158/1538-7445.AM2018-1917
Details DOI
-
2019 | Journal Article |
The histone methyltransferase DOT1L is required for proper DNA damage response, DNA repair, and modulates chemotherapy responsiveness
Kari, V.; Raul, S. K; Henck, J. M; Kitz, J.; Kramer, F.; Kosinsky, R. L & Übelmesser, N. et al. (2019)
Clinical Epigenetics, 11(1) art. 4. DOI: https://doi.org/10.1186/s13148-018-0601-1
Details DOI
-
2019 | Journal Article |
The E3 ubiquitin ligase RNF40 suppresses apoptosis in colorectal cancer cells
Schneider, D.; Chua, R. L; Molitor, N.; Hamdan, F. H; Rettenmeier, E. M; Prokakis, E. & Mishra, V. K et al. (2019)
Clinical Epigenetics, 11(1) art. 98. DOI: https://doi.org/10.1186/s13148-019-0698-x
Details DOI
-
2019 | Journal Article |
Cytosolic 5'-nucleotidase 1A is overexpressed in pancreatic cancer and mediates gemcitabine resistance by reducing intracellular gemcitabine metabolites.
Patzak, M. S.; Kari, V.; Patil, S.; Hamdan, F. H.; Goetze, R. G.; Brunner, M. & Gaedcke, J. et al. (2019)
EBioMedicine, 40 pp. 394-405. DOI: https://doi.org/10.1016/j.ebiom.2019.01.037
Details DOI PMID PMC